The Atlas Study: A Clinical Trial For Adults With A Confirmed Sod1 Mutation Without Symptoms Of Als

The ATLAS Study: A Clinical Trial for Adults with a Confirmed SOD1 Mutation without Symptoms of ALS

MDA

The Expanding Landscape of Therapeutic Targets in ALS Clinical Trials

Johns Hopkins Medicine

Updates in Amyotrophic Lateral Sclerosis (ALS)

MDA

Tofersen helps people with ALS caused by an SOD1 mutation

TPN-101 Clinical Trial: for ALS & the C9orf72 Mutation - an Overview of the Trial plus Q&A

Thoughts on Clinical Trials from the Perspectives of an ALS Center Director

Drug for rare form of ALS benefits some patients

Tofersen Approved for SOD1-ALS

The ALS Association

Lessons in patience gained from the tofersen clinical trials

ALS Clinical Trials

ALS｜Racing Against Time to Treat Amyotrophic Lateral Sclerosis, A Fatal Disease

Understanding Tofersen’s Impact on SOD1 ALS, Neurofilament Light

Clinical Trials Webinar 2: ALS Clinical Trial Overview

Results of Clinical Trials for CNM-Au8, A Potential ALS Treatment

2021 Neuroscience Symposium | Breaking Update: ALS Clinical Trials

Total Health | Oncology

SOD1 and TDP43 mutations in ALS

Unanswered questions in ALS research

2011, Professor Orla Hardiman, Clinical Trials in ALS/MND: Past, Present and Future

Assessing the role of measuring plasma neurofilament light levels in ALS

Problems and Progress in ALS Clinical Trials

Johns Hopkins Medicine